Healthcare Sector Stocks
The Healthcare sector has a total of 1067 stocks, with a combined market cap of $8.25 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.04.
Market Cap
8.25T
Revenue
4.52T
Profits
201.02B
PE Ratio
41.04
Profit Margin
4.44%
Dividend Yield
0.44%
1068 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 818.11B | -0.78% | 1,010,037 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 555.06B | 1.92% | 2,992,487 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 355.36B | 0.20% | 3,071,608 | 61.16B |
| 4 | UNH | UnitedHealth Group Incorporated | 320.72B | -0.11% | 4,130,844 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 304.55B | -0.81% | 824,519 | 58.74B |
| 6 | MRK | Merck & Co., Inc. | 282.44B | 1.30% | 3,391,743 | 65.01B |
| 7 | NVS | Novartis AG | 281.78B | -0.28% | 786,070 | 56.67B |
| 8 | AMGN | Amgen Inc. | 188.13B | 0.77% | 791,591 | 36.75B |
| 9 | NVO | Novo Nordisk A/S | 173.29B | -1.90% | 7,239,246 | 48.59B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 170.33B | -10.83% | 3,488,098 | 45.20B |
| 11 | ISRG | Intuitive Surgical, Inc. | 170.00B | -0.75% | 1,413,967 | 10.58B |
| 12 | GILD | Gilead Sciences, Inc. | 165.64B | 0.41% | 1,412,512 | 29.44B |
| 13 | ABT | Abbott Laboratories | 158.53B | -0.74% | 5,354,336 | 45.13B |
| 14 | PFE | Pfizer Inc. | 150.29B | -1.42% | 18,216,845 | 62.58B |
| 15 | DHR | Danaher Corporation | 125.66B | -3.53% | 5,662,365 | 24.78B |
| 16 | SYK | Stryker Corporation | 124.94B | -0.95% | 572,100 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.45B | 0.33% | 2,184,528 | 48.19B |
| 18 | SNY | Sanofi | 115.65B | 1.58% | 3,557,844 | 54.85B |
| 19 | GSK | GSK plc | 111.98B | 0.07% | 1,636,937 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 111.11B | -0.19% | 282,554 | 12.00B |
| 21 | MDT | Medtronic plc | 106.73B | -0.11% | 3,285,496 | 35.48B |
| 22 | HCA | HCA Healthcare, Inc. | 106.52B | 1.09% | 378,134 | 75.60B |
| 23 | MCK | McKesson Corporation | 101.32B | -0.24% | 273,849 | 397.96B |
| 24 | CVS | CVS Health Corporation | 100.48B | 2.58% | 3,183,015 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 97.76B | 1.40% | 14,685,640 | 20.61B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.94B | 1.73% | 429,804 | 14.34B |
| 27 | ELV | Elevance Health, Inc. | 74.97B | 5.18% | 959,438 | 200.42B |
| 28 | CI | The Cigna Group | 73.00B | 0.79% | 677,296 | 274.90B |
| 29 | MDLN | Medline Inc. | 60.38B | -2.54% | 1,840,800 | 28.43B |
| 30 | COR | Cencora, Inc. | 59.33B | -1.07% | 484,311 | 325.78B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 52.84B | -0.06% | 937,914 | 28.48B |
| 32 | ARGX | argenx SE | 49.44B | 0.23% | 128,033 | 4.24B |
| 33 | ZTS | Zoetis Inc. | 48.63B | -1.59% | 1,501,702 | 9.47B |
| 34 | CAH | Cardinal Health, Inc. | 47.50B | 0.65% | 547,835 | 244.67B |
| 35 | EW | Edwards Lifesciences Corporation | 45.82B | -2.53% | 2,436,952 | 6.07B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.39B | -3.35% | 169,549 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 44.02B | -0.68% | 1,184,859 | 21.92B |
| 38 | HLN | Haleon plc | 41.62B | 1.18% | 5,017,226 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.47B | 0.67% | 258,774 | 3.71B |
| 40 | ALC | Alcon Inc. | 37.62B | -0.97% | 618,049 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 35.96B | -1.09% | 1,695,785 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 33.32B | -3.83% | 188,399 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 31.97B | -6.08% | 1,105,673 | 7.07B |
| 44 | GEHC | GE HealthCare Technologies Inc. | 31.90B | -2.06% | 1,201,472 | 20.63B |
| 45 | RMD | ResMed Inc. | 31.65B | -1.73% | 316,353 | 5.40B |
| 46 | INSM | Insmed Incorporated | 30.86B | -1.04% | 513,372 | 606.42M |
| 47 | WAT | Waters Corporation | 30.29B | -7.71% | 688,479 | 3.17B |
| 48 | RPRX | Royalty Pharma plc | 29.37B | -0.36% | 1,063,414 | 2.38B |
| 49 | RVMD | Revolution Medicines, Inc. | 28.41B | -4.54% | 2,250,324 | - |
| 50 | BIIB | Biogen Inc. | 27.59B | -1.09% | 309,385 | 9.89B |
| 51 | NTRA | Natera, Inc. | 27.50B | -6.63% | 674,215 | 2.31B |
| 52 | PHG | Koninklijke Philips N.V. | 26.98B | -2.44% | 670,938 | 20.94B |
| 53 | BNTX | BioNTech SE | 26.81B | -2.38% | 292,132 | 3.37B |
| 54 | IQV | IQVIA Holdings Inc. | 26.48B | -9.95% | 1,009,017 | 16.31B |
| 55 | HUM | Humana Inc. | 25.74B | -1.37% | 334,290 | 129.66B |
| 56 | MTD | Mettler-Toledo International Inc. | 25.09B | -5.42% | 66,206 | 4.03B |
| 57 | VEEV | Veeva Systems Inc. | 25.08B | -6.26% | 1,714,525 | 3.20B |
| 58 | UTHR | United Therapeutics Corporation | 25.04B | -0.50% | 94,777 | 3.18B |
| 59 | DXCM | DexCom, Inc. | 24.10B | -1.50% | 1,043,198 | 4.66B |
| 60 | WST | West Pharmaceutical Services, Inc. | 22.29B | 12.69% | 1,454,810 | 3.22B |
| 61 | DGX | Quest Diagnostics Incorporated | 21.97B | -2.73% | 378,273 | 11.28B |
| 62 | STE | STERIS plc | 21.74B | -0.84% | 150,603 | 5.83B |
| 63 | LH | Labcorp Holdings Inc. | 21.51B | -3.99% | 440,046 | 13.95B |
| 64 | MRNA | Moderna, Inc. | 21.30B | -3.42% | 1,838,811 | 1.94B |
| 65 | ROIV | Roivant Sciences Ltd. | 20.33B | -2.54% | 1,852,544 | 13.31M |
| 66 | CNC | Centene Corporation | 19.78B | 3.31% | 1,864,501 | 176.15B |
| 67 | INCY | Incyte Corporation | 19.01B | -1.24% | 323,600 | 5.14B |
| 68 | ILMN | Illumina, Inc. | 18.64B | -5.99% | 757,522 | 4.34B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 17.81B | -1.12% | 686,838 | 8.23B |
| 70 | SMMT | Summit Therapeutics Inc. | 17.66B | -7.40% | 3,038,015 | - |
| 71 | GMAB | Genmab A/S | 17.10B | -2.56% | 483,106 | 3.72B |
| 72 | VTRS | Viatris Inc. | 16.99B | 0.48% | 3,104,766 | 14.30B |
| 73 | THC | Tenet Healthcare Corporation | 16.60B | -0.94% | 422,659 | 21.31B |
| 74 | ASND | Ascendis Pharma A/S | 14.02B | -1.76% | 488,675 | 845.52M |
| 75 | SNN | Smith & Nephew plc | 14.01B | -2.57% | 903,134 | 6.16B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 13.97B | -3.17% | 1,530,370 | 502.08M |
| 77 | RGC | Regencell Bioscience Holdings Limited | 13.92B | -3.89% | 46,681 | - |
| 78 | ALGN | Align Technology, Inc. | 13.55B | -3.46% | 341,160 | 4.03B |
| 79 | PODD | Insulet Corporation | 13.22B | -1.42% | 346,329 | 2.71B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 13.16B | -0.27% | 166,633 | 2.86B |
| 81 | PEN | Penumbra, Inc. | 13.11B | 0.32% | 286,287 | 1.40B |
| 82 | GMED | Globus Medical, Inc. | 12.75B | -0.80% | 175,428 | 2.94B |
| 83 | COO | The Cooper Companies, Inc. | 12.68B | -2.88% | 1,002,997 | 4.15B |
| 84 | FMS | Fresenius Medical Care AG | 12.33B | -0.63% | 223,955 | 23.05B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.32B | -0.37% | 571,665 | 943.71M |
| 86 | JAZZ | Jazz Pharmaceuticals plc | 12.25B | -1.68% | 291,052 | 4.27B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.98B | -1.30% | 84,317 | 958.40M |
| 88 | SOLV | Solventum Corporation | 11.86B | -1.03% | 280,417 | 8.33B |
| 89 | RDY | Dr. Reddy's Laboratories Limited | 11.83B | 4.87% | 4,097,497 | 3.85B |
| 90 | EXEL | Exelixis, Inc. | 11.73B | -1.45% | 924,400 | 2.32B |
| 91 | MEDP | Medpace Holdings, Inc. | 11.07B | -23.79% | 1,114,283 | 2.53B |
| 92 | UHS | Universal Health Services, Inc. | 11.06B | 0.32% | 183,707 | 17.36B |
| 93 | GH | Guardant Health, Inc. | 11.04B | -6.02% | 696,091 | 982.02M |
| 94 | ENSG | The Ensign Group, Inc. | 11.01B | 1.17% | 186,509 | 5.06B |
| 95 | ELAN | Elanco Animal Health Incorporated | 10.96B | -2.32% | 1,532,284 | 4.72B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.67B | 3.08% | 1,273,902 | 1.09B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.32B | -0.90% | 554,336 | 3.22B |
| 98 | DVA | DaVita Inc. | 10.18B | 1.32% | 288,379 | 13.64B |
| 99 | EHC | Encompass Health Corporation | 10.07B | -0.84% | 203,670 | 5.94B |
| 100 | BTSG | BrightSpring Health Services, Inc. | 9.49B | -1.78% | 483,019 | 12.91B |
| 101 | BAX | Baxter International Inc. | 9.45B | -0.05% | 1,738,665 | 11.24B |
| 102 | RVTY | Revvity, Inc. | 9.38B | -10.99% | 1,180,556 | 2.86B |
| 103 | AXSM | Axsome Therapeutics, Inc. | 9.35B | -1.90% | 210,008 | 638.50M |
| 104 | PRAX | Praxis Precision Medicines, Inc. | 9.32B | -0.82% | 169,504 | 7.46M |
| 105 | MASI | Masimo Corporation | 9.32B | -0.03% | 221,865 | 1.53B |
| 106 | ABVX | ABIVAX Société Anonyme | 9.20B | -2.63% | 341,080 | 5.37M |
| 107 | TEM | Tempus AI, Inc. | 9.14B | -8.12% | 3,552,126 | 1.27B |
| 108 | HSIC | Henry Schein, Inc. | 8.92B | -0.44% | 385,109 | 13.18B |
| 109 | MOH | Molina Healthcare, Inc. | 8.84B | 10.89% | 1,742,152 | 43.21B |
| 110 | PCVX | Vaxcyte, Inc. | 8.56B | -2.14% | 356,126 | - |
| 111 | NUVL | Nuvalent, Inc. | 8.40B | -1.85% | 415,317 | - |
| 112 | CRL | Charles River Laboratories International, Inc. | 8.32B | -8.81% | 613,655 | 4.02B |
| 113 | IBRX | ImmunityBio, Inc. | 8.18B | -1.80% | 5,597,441 | 113.29M |
| 114 | ICLR | ICON Public Limited Company | 8.17B | -7.30% | 958,943 | 8.10B |
| 115 | TECH | Bio-Techne Corporation | 8.07B | -11.90% | 1,589,942 | 1.22B |
| 116 | CYTK | Cytokinetics, Incorporated | 8.03B | -2.46% | 756,613 | 88.04M |
| 117 | ATR | AptarGroup, Inc. | 8.02B | 1.00% | 124,132 | 3.78B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.97B | -1.68% | 966,853 | 1.40B |
| 119 | KRYS | Krystal Biotech, Inc. | 7.94B | -2.28% | 82,327 | 389.13M |
| 120 | QGEN | Qiagen N.V. | 7.79B | -5.73% | 1,257,356 | 2.09B |
| 121 | BIO | Bio-Rad Laboratories, Inc. | 7.47B | -8.04% | 220,188 | 2.58B |
| 122 | ERAS | Erasca, Inc. | 7.09B | 5.40% | 5,422,583 | - |
| 123 | KYMR | Kymera Therapeutics, Inc. | 7.08B | -2.27% | 143,719 | 39.21M |
| 124 | GKOS | Glaukos Corporation | 7.05B | -0.88% | 217,918 | 507.44M |
| 125 | HQY | HealthEquity, Inc. | 6.79B | -2.96% | 305,903 | 1.31B |
| 126 | ACLX | Arcellx, Inc. | 6.75B | 0.05% | 775,556 | 22.29M |
| 127 | GRFS | Grifols, S.A. | 6.73B | -4.53% | 292,364 | 8.83B |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.58B | -2.27% | 132,236 | 46.02M |
| 129 | APGE | Apogee Therapeutics, Inc. | 6.52B | -2.66% | 161,070 | - |
| 130 | BLTE | Belite Bio, Inc | 6.48B | -1.63% | 20,140 | - |
| 131 | HIMS | Hims & Hers Health, Inc. | 6.33B | -4.31% | 30,875,334 | 2.35B |
| 132 | RGEN | Repligen Corporation | 6.28B | -10.45% | 1,009,156 | 738.26M |
| 133 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.08% | 1,453,594 | 15.00M |
| 134 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | -0.02% | 1,341,704 | - |
| 135 | SYRE | Spyre Therapeutics, Inc. | 6.03B | -4.30% | 226,825 | - |
| 136 | TFX | Teleflex Incorporated | 6.00B | -2.32% | 364,275 | 1.99B |
| 137 | IMVT | Immunovant, Inc. | 5.90B | -1.76% | 702,742 | - |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.83B | 0.23% | 189,688 | 189.76M |
| 139 | CGON | CG Oncology, Inc. | 5.76B | -2.33% | 546,345 | 4.04M |
| 140 | COGT | Cogent Biosciences, Inc. | 5.75B | -1.92% | 338,014 | - |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.74B | -2.16% | 289,417 | 1.73B |
| 142 | ALKS | Alkermes plc | 5.63B | 0.36% | 394,355 | 1.48B |
| 143 | BLCO | Bausch + Lomb Corporation | 5.62B | -1.68% | 332,884 | 5.10B |
| 144 | TGTX | TG Therapeutics, Inc. | 5.54B | -2.06% | 696,936 | 616.29M |
| 145 | CAI | Caris Life Sciences, Inc. | 5.53B | -4.59% | 822,842 | 812.03M |
| 146 | CELC | Celcuity Inc. | 5.53B | -6.60% | 305,878 | - |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 5.52B | -2.92% | 139,776 | 521.31M |
| 148 | PACS | PACS Group, Inc. | 5.47B | -0.49% | 218,916 | 5.29B |
| 149 | SRRK | Scholar Rock Holding Corporation | 5.43B | -0.05% | 415,967 | - |
| 150 | BRKR | Bruker Corporation | 5.39B | -10.81% | 1,945,314 | 3.44B |
| 151 | LNTH | Lantheus Holdings, Inc. | 5.35B | -0.62% | 105,068 | 1.54B |
| 152 | CRSP | CRISPR Therapeutics AG | 5.35B | -1.62% | 791,258 | 3.51M |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.31B | -1.82% | 208,265 | 7.50M |
| 154 | APLS | Apellis Pharmaceuticals, Inc. | 5.23B | -0.01% | 1,491,812 | 1.00B |
| 155 | AVTR | Avantor, Inc. | 5.10B | -8.94% | 5,914,663 | 6.55B |
| 156 | CHE | Chemed Corporation | 5.05B | 0.91% | 94,926 | 2.53B |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.97B | -0.05% | 141,470 | 2.04M |
| 158 | CORT | Corcept Therapeutics Incorporated | 4.80B | -3.97% | 489,450 | 761.41M |
| 159 | OSCR | Oscar Health, Inc. | 4.79B | -2.13% | 1,865,786 | 11.70B |
| 160 | WAY | Waystar Holding Corp. | 4.66B | -4.14% | 990,333 | 1.10B |
| 161 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.03% | 1,100,611 | 634.21M |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 4.54B | 0.27% | 120,623 | 268.09M |
| 163 | STVN | Stevanato Group S.p.A. | 4.49B | 5.62% | 508,320 | 1.39B |
| 164 | LEGN | Legend Biotech Corporation | 4.46B | -7.10% | 1,245,227 | 1.03B |
| 165 | OPCH | Option Care Health, Inc. | 4.44B | -0.25% | 372,021 | 5.65B |
| 166 | RDNT | RadNet, Inc. | 4.43B | -2.18% | 210,967 | 2.04B |
| 167 | SHC | Sotera Health Company | 4.36B | -2.11% | 762,739 | 1.16B |
| 168 | NVST | Envista Holdings Corporation | 4.36B | -1.51% | 635,082 | 2.72B |
| 169 | DOCS | Doximity, Inc. | 4.24B | -5.28% | 1,104,563 | 637.78M |
| 170 | ALHC | Alignment Healthcare, Inc. | 4.23B | -1.43% | 685,454 | 3.95B |
| 171 | MMSI | Merit Medical Systems, Inc. | 4.11B | -1.13% | 235,145 | 1.52B |
| 172 | AMRX | Amneal Pharmaceuticals, Inc. | 4.04B | -1.33% | 723,013 | 3.02B |
| 173 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.01B | -2.05% | 282,722 | 7.70M |
| 174 | TMDX | TransMedics Group, Inc. | 3.92B | -0.94% | 499,517 | 605.49M |
| 175 | IRTC | iRhythm Holdings, Inc. | 3.92B | -1.59% | 63,471 | 747.14M |
| 176 | VKTX | Viking Therapeutics, Inc. | 3.87B | -2.63% | 884,310 | - |
| 177 | BLLN | BillionToOne, Inc. | 3.85B | -3.65% | 210,953 | 305.11M |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | -1.26% | 412,689 | 1.07B |
| 179 | MMED | MiniMed Group, Inc. | 3.73B | 0.76% | 348,485 | 2.99B |
| 180 | TVTX | Travere Therapeutics, Inc. | 3.71B | 0.07% | 756,850 | 490.73M |
| 181 | TNGX | Tango Therapeutics, Inc. | 3.68B | -5.42% | 1,185,039 | 62.38M |
| 182 | NAMS | NewAmsterdam Pharma Company N.V. | 3.63B | -1.28% | 249,580 | 22.50M |
| 183 | TWST | Twist Bioscience Corporation | 3.54B | -8.72% | 764,710 | 391.56M |
| 184 | LIVN | LivaNova PLC | 3.53B | -0.95% | 116,125 | 1.39B |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.50B | -1.95% | 74,008 | 803.79M |
| 186 | ORKA | Oruka Therapeutics, Inc. | 3.43B | -2.05% | 1,123,444 | - |
| 187 | EWTX | Edgewise Therapeutics, Inc. | 3.38B | -2.05% | 346,582 | - |
| 188 | ALMS | Alumis Inc. | 3.36B | 2.09% | 1,178,158 | 24.05M |
| 189 | GPCR | Structure Therapeutics Inc. | 3.34B | 1.46% | 425,363 | - |
| 190 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.34B | 0.88% | 249,465 | 677.56M |
| 191 | HNGE | Hinge Health, Inc. | 3.34B | -3.66% | 219,672 | 587.86M |
| 192 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.30B | 4.20% | 1,345,602 | 588.99M |
| 193 | LQDA | Liquidia Corporation | 3.25B | -0.49% | 243,753 | 158.32M |
| 194 | BKD | Brookdale Senior Living Inc. | 3.19B | 0.07% | 566,361 | 3.05B |
| 195 | ICUI | ICU Medical, Inc. | 3.12B | -2.10% | 94,463 | 2.23B |
| 196 | DYN | Dyne Therapeutics, Inc. | 3.11B | -4.37% | 745,972 | - |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.11B | -6.91% | 783,756 | 247.00M |
| 198 | KLRA | Kailera Therapeutics, Inc. | 3.10B | 3.05% | 734,287 | - |
| 199 | DNLI | Denali Therapeutics Inc. | 3.08B | -4.05% | 447,718 | - |
| 200 | BEAM | Beam Therapeutics Inc. | 3.04B | -4.17% | 1,206,908 | 139.74M |
| 201 | CON | Concentra Group Holdings Parent, Inc. | 2.94B | 1.15% | 326,221 | 2.16B |
| 202 | NKTR | Nektar Therapeutics | 2.94B | -4.94% | 1,091,462 | 55.23M |
| 203 | PRVA | Privia Health Group, Inc. | 2.94B | -1.89% | 207,256 | 2.12B |
| 204 | RLAY | Relay Therapeutics, Inc. | 2.92B | -6.60% | 1,169,497 | 15.36M |
| 205 | SUPN | Supernus Pharmaceuticals, Inc. | 2.90B | 0.25% | 94,057 | 718.95M |
| 206 | ITGR | Integer Holdings Corporation | 2.89B | -0.26% | 472,298 | 1.85B |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 2.82B | -4.25% | 485,298 | 376.07M |
| 208 | KOD | Kodiak Sciences Inc. | 2.80B | 0.44% | 166,615 | - |
| 209 | WRBY | Warby Parker Inc. | 2.78B | -7.57% | 890,963 | 871.91M |
| 210 | VERA | Vera Therapeutics, Inc. | 2.73B | -5.31% | 295,141 | - |
| 211 | SLNO | Soleno Therapeutics, Inc. | 2.73B | - | 731,974 | 190.41M |
| 212 | HAE | Haemonetics Corporation | 2.72B | -4.11% | 648,617 | 1.32B |
| 213 | HTFL | HeartFlow, Inc. | 2.72B | -3.64% | 193,139 | 176.03M |
| 214 | IDYA | IDEAYA Biosciences, Inc. | 2.70B | -2.87% | 654,325 | 218.71M |
| 215 | LFST | LifeStance Health Group, Inc. | 2.70B | 0.14% | 558,736 | 1.42B |
| 216 | PBH | Prestige Consumer Healthcare Inc. | 2.67B | -1.31% | 339,105 | 1.10B |
| 217 | TXG | 10x Genomics, Inc. | 2.66B | -8.89% | 1,960,036 | 642.82M |
| 218 | NHC | National HealthCare Corporation | 2.65B | -2.33% | 122,635 | 1.52B |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.64B | -1.72% | 280,650 | 1.55M |
| 220 | IRON | Disc Medicine, Inc. | 2.63B | -1.32% | 86,636 | - |
| 221 | IMNM | Immunome, Inc. | 2.60B | -3.28% | 230,986 | 6.94M |
| 222 | MANE | Veradermics, Incorporated | 2.60B | -1.07% | 115,130 | - |
| 223 | ADMA | ADMA Biologics, Inc. | 2.60B | 2.01% | 2,128,192 | 510.17M |
| 224 | ELVN | Enliven Therapeutics, Inc. | 2.59B | -2.39% | 163,328 | - |
| 225 | TARS | Tarsus Pharmaceuticals, Inc. | 2.59B | -4.20% | 296,308 | 451.36M |
| 226 | VCYT | Veracyte, Inc. | 2.56B | -4.24% | 403,959 | 517.15M |
| 227 | LMAT | LeMaitre Vascular, Inc. | 2.56B | -0.56% | 42,422 | 249.60M |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.50B | -2.86% | 686,586 | 3.31B |
| 229 | ZLAB | Zai Lab Limited | 2.44B | -5.03% | 296,824 | 460.16M |
| 230 | RARE | Ultragenyx Pharmaceutical Inc. | 2.37B | -1.95% | 400,240 | 673.00M |
| 231 | XRAY | DENTSPLY SIRONA Inc. | 2.36B | -3.00% | 722,255 | 3.68B |
| 232 | HCM | HUTCHMED (China) Limited | 2.33B | -3.57% | 27,682 | 548.51M |
| 233 | DFTX | Definium Therapeutics, Inc. | 2.32B | 0.91% | 1,215,271 | - |
| 234 | GRDN | Guardian Pharmacy Services, Inc. | 2.32B | 1.10% | 130,259 | 1.45B |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.31B | -2.97% | 244,256 | - |
| 236 | OGN | Organon & Co. | 2.24B | -5.91% | 2,065,190 | 6.22B |
| 237 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | - | - | 158.18M |
| 238 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.22B | -1.89% | 917,315 | 874.84M |
| 239 | PAHC | Phibro Animal Health Corporation | 2.20B | 0.63% | 67,819 | 1.46B |
| 240 | TYRA | Tyra Biosciences, Inc. | 2.20B | -1.10% | 287,190 | - |
| 241 | AAPG | Ascentage Pharma Group International | 2.15B | -6.55% | 4,619 | 82.08M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -1.83% | 600,684 | 283.06M |
| 243 | ADPT | Adaptive Biotechnologies Corporation | 2.10B | -3.94% | 432,068 | 276.98M |
| 244 | SRPT | Sarepta Therapeutics, Inc. | 2.09B | -3.49% | 3,292,068 | 2.20B |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.08B | -2.12% | 113,920 | 184.42M |
| 246 | BHC | Bausch Health Companies Inc. | 2.07B | -2.29% | 948,485 | 10.27B |
| 247 | OCUL | Ocular Therapeutix, Inc. | 2.06B | -2.07% | 602,862 | 51.95M |
| 248 | ZYME | Zymeworks Inc. | 2.04B | -3.08% | 279,280 | 105.97M |
| 249 | SEM | Select Medical Holdings Corporation | 2.04B | -0.06% | 183,232 | 5.45B |
| 250 | NEOG | Neogen Corporation | 2.03B | -1.89% | 1,336,742 | 870.56M |
| 251 | GRAL | GRAIL, Inc. | 2.03B | -5.80% | 298,374 | 147.17M |
| 252 | MESO | Mesoblast Limited | 2.02B | -2.48% | 47,963 | 65.38M |
| 253 | TRVI | Trevi Therapeutics, Inc. | 1.99B | -4.19% | 1,001,265 | - |
| 254 | AXGN | Axogen, Inc. | 1.94B | 1.03% | 421,161 | 225.21M |
| 255 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.92B | -0.80% | 163,267 | -665.00K |
| 256 | GLPG | Galapagos NV | 1.92B | -1.34% | 50,300 | 1.31B |
| 257 | CAPR | Capricor Therapeutics, Inc. | 1.91B | -5.49% | 441,294 | 11.13M |
| 258 | ESTA | Establishment Labs Holdings Inc. | 1.91B | -3.10% | 106,829 | 211.08M |
| 259 | SGRY | Surgery Partners, Inc. | 1.91B | 0.88% | 431,399 | 3.31B |
| 260 | WGS | GeneDx Holdings Corp. | 1.90B | -7.09% | 298,968 | 427.54M |
| 261 | NTLA | Intellia Therapeutics, Inc. | 1.90B | -3.02% | 1,729,900 | 67.67M |
| 262 | PHVS | Pharvaris N.V. | 1.89B | -3.83% | 86,919 | - |
| 263 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | -4.26% | 1,419,506 | 172.35M |
| 264 | TSHA | Taysha Gene Therapies, Inc. | 1.86B | -3.65% | 953,885 | 9.77M |
| 265 | MD | Pediatrix Medical Group, Inc. | 1.86B | 0.09% | 117,717 | 1.91B |
| 266 | HRMY | Harmony Biosciences Holdings, Inc. | 1.84B | -0.34% | 497,024 | 868.45M |
| 267 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | -6.57% | 6,085,016 | 74.68M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.81B | -3.33% | 56,901 | - |
| 269 | SION | Sionna Therapeutics, Inc. | 1.80B | -7.41% | 137,251 | - |
| 270 | ANIP | ANI Pharmaceuticals, Inc. | 1.79B | -1.81% | 94,059 | 883.37M |
| 271 | AORT | Artivion, Inc. | 1.79B | -0.57% | 52,572 | 441.33M |
| 272 | AHG | Akso Health Group | 1.77B | 4.29% | 181,506 | 14.84M |
| 273 | INBX | Inhibrx Biosciences, Inc. | 1.76B | 4.99% | 563,318 | 1.30M |
| 274 | NUVB | Nuvation Bio Inc. | 1.76B | -1.17% | 1,253,541 | 62.90M |
| 275 | RAPP | Rapport Therapeutics, Inc. | 1.75B | -0.71% | 195,480 | - |
| 276 | ATAI | AtaiBeckley Inc. | 1.75B | 1.59% | 6,290,752 | 4.09M |
| 277 | INVA | Innoviva, Inc. | 1.73B | -0.62% | 141,121 | 411.33M |
| 278 | NRIX | Nurix Therapeutics, Inc. | 1.73B | 0.54% | 334,233 | 71.78M |
| 279 | AHCO | AdaptHealth Corp. | 1.71B | -0.87% | 547,394 | 3.24B |
| 280 | VCEL | Vericel Corporation | 1.71B | -2.30% | 229,234 | 276.26M |
| 281 | ADUS | Addus HomeCare Corporation | 1.70B | -1.16% | 111,554 | 1.42B |
| 282 | VIR | Vir Biotechnology, Inc. | 1.66B | -3.56% | 570,631 | 68.56M |
| 283 | PLSE | Pulse Biosciences, Inc. | 1.64B | -1.23% | 60,337 | 350.00K |
| 284 | OMCL | Omnicell, Inc. | 1.63B | -1.94% | 181,592 | 1.18B |
| 285 | GENB | Generate Biomedicines, Inc. | 1.62B | -2.23% | 141,905 | 31.89M |
| 286 | ALMR | Alamar Biosciences, Inc. | 1.62B | -2.06% | 130,046 | 74.21M |
| 287 | ASTH | Astrana Health, Inc. | 1.62B | -2.82% | 140,665 | 3.18B |
| 288 | GLUE | Monte Rosa Therapeutics, Inc. | 1.60B | -4.48% | 341,617 | 123.67M |
| 289 | PRGO | Perrigo Company plc | 1.60B | -1.57% | 583,586 | 4.25B |
| 290 | SNDA | Sonida Senior Living, Inc. | 1.60B | 0.40% | 287,806 | 336.39M |
| 291 | MBX | MBX Biosciences, Inc. | 1.59B | -0.10% | 362,219 | - |
| 292 | INSP | Inspire Medical Systems, Inc. | 1.58B | 1.33% | 507,253 | 911.98M |
| 293 | OCS | Oculis Holding AG | 1.57B | -4.85% | 196,490 | 1.51M |
| 294 | BHVN | Biohaven Ltd. | 1.56B | -2.72% | 630,350 | - |
| 295 | DMRA | Damora Therapeutics, Inc. | 1.56B | -0.08% | 59,526 | - |
| 296 | ATEC | Alphatec Holdings, Inc. | 1.54B | -4.33% | 910,708 | 764.16M |
| 297 | NBTX | Nanobiotix S.A. | 1.54B | 3.87% | 79,179 | 38.27M |
| 298 | AGIO | Agios Pharmaceuticals, Inc. | 1.52B | -2.73% | 433,619 | 54.03M |
| 299 | UFPT | UFP Technologies, Inc. | 1.52B | -3.13% | 139,145 | 602.80M |
| 300 | HCSG | Healthcare Services Group, Inc. | 1.52B | -3.76% | 745,870 | 1.85B |
| 301 | BCAX | Bicara Therapeutics Inc. | 1.50B | -3.28% | 166,550 | - |
| 302 | ANAB | AnaptysBio, Inc. | 1.49B | -3.49% | 162,397 | 234.60M |
| 303 | IMCR | Immunocore Holdings plc | 1.49B | -2.54% | 115,049 | 400.02M |
| 304 | IMTX | Immatics N.V. | 1.48B | -2.31% | 96,682 | 56.67M |
| 305 | VRDN | Viridian Therapeutics, Inc. | 1.45B | -1.61% | 440,379 | 70.85M |
| 306 | ARDX | Ardelyx, Inc. | 1.45B | -1.83% | 1,105,369 | 407.32M |
| 307 | NVCR | NovoCure Limited | 1.44B | -4.84% | 331,589 | 655.35M |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.43B | -2.42% | 281,702 | 2.50M |
| 309 | HROW | Harrow, Inc. | 1.42B | -2.38% | 291,447 | 272.30M |
| 310 | AVAH | Aveanna Healthcare Holdings Inc. | 1.41B | - | 394,914 | 2.43B |
| 311 | IOVA | Iovance Biotherapeutics, Inc. | 1.40B | -3.40% | 7,431,927 | 263.50M |
| 312 | TNDM | Tandem Diabetes Care, Inc. | 1.40B | -1.35% | 631,185 | 1.01B |
| 313 | WVE | Wave Life Sciences Ltd. | 1.40B | -1.36% | 1,145,159 | 42.73M |
| 314 | ARDT | Ardent Health, Inc. | 1.39B | -1.52% | 137,594 | 6.32B |
| 315 | ATRC | AtriCure, Inc. | 1.38B | -1.19% | 214,467 | 534.53M |
| 316 | PRCT | PROCEPT BioRobotics Corporation | 1.37B | -2.99% | 568,173 | 308.05M |
| 317 | PGEN | Precigen, Inc. | 1.37B | -2.15% | 1,850,897 | 9.68M |
| 318 | PGNY | Progyny, Inc. | 1.36B | -3.31% | 397,709 | 1.29B |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.35B | -0.83% | 176,237 | - |
| 320 | CRVS | Corvus Pharmaceuticals, Inc. | 1.34B | -10.36% | 1,094,184 | - |
| 321 | OLMA | Olema Pharmaceuticals, Inc. | 1.34B | -5.48% | 306,957 | - |
| 322 | BFLY | Butterfly Network, Inc. | 1.33B | -5.42% | 3,470,708 | 97.61M |
| 323 | KMTS | Kestra Medical Technologies, Ltd. | 1.33B | -4.66% | 95,670 | 83.72M |
| 324 | NVAX | Novavax, Inc. | 1.31B | -4.73% | 1,892,738 | 1.12B |
| 325 | CLOV | Clover Health Investments, Corp. | 1.30B | -1.00% | 3,517,192 | 1.92B |
| 326 | ENOV | Enovis Corporation | 1.28B | -6.10% | 681,552 | 2.25B |
| 327 | MPLT | MapLight Therapeutics, Inc. | 1.27B | -10.52% | 245,862 | - |
| 328 | SVRA | Savara Inc. | 1.27B | -2.92% | 685,950 | - |
| 329 | CMPS | COMPASS Pathways plc | 1.25B | 5.60% | 3,029,732 | - |
| 330 | NNNN | Anbio Biotechnology | 1.23B | -1.32% | 8,334 | 8.65M |
| 331 | STAA | STAAR Surgical Company | 1.22B | -0.48% | 530,764 | 239.44M |
| 332 | JBIO | Jade Biosciences, Inc. | 1.22B | -2.48% | 216,390 | - |
| 333 | MLTX | MoonLake Immunotherapeutics | 1.21B | -2.09% | 238,769 | - |
| 334 | ABCL | AbCellera Biologics Inc. | 1.21B | -2.57% | 5,161,467 | 75.13M |
| 335 | PHAR | Pharming Group N.V. | 1.20B | -1.35% | 1,289 | 376.13M |
| 336 | AKTS | Aktis Oncology, Inc. | 1.19B | -2.23% | 119,867 | 6.50M |
| 337 | URGN | UroGen Pharma Ltd. | 1.16B | -8.25% | 436,080 | 109.79M |
| 338 | DBVT | DBV Technologies S.A. | 1.16B | -2.16% | 120,475 | 5.64M |
| 339 | AVNS | Avanos Medical, Inc. | 1.15B | -0.02% | 518,440 | 701.20M |
| 340 | SEPN | Septerna, Inc. | 1.15B | -0.97% | 166,695 | 45.95M |
| 341 | GHRS | GH Research PLC | 1.15B | -2.30% | 175,691 | - |
| 342 | EYPT | EyePoint, Inc. | 1.15B | -3.37% | 366,817 | 31.37M |
| 343 | CNMD | CONMED Corporation | 1.15B | -1.20% | 148,816 | 1.37B |
| 344 | IRMD | IRADIMED CORPORATION | 1.14B | -0.64% | 29,921 | 83.81M |
| 345 | USPH | U.S. Physical Therapy, Inc. | 1.14B | -0.05% | 57,902 | 773.34M |
| 346 | AZTA | Azenta, Inc. | 1.13B | -7.07% | 538,966 | 595.03M |
| 347 | EVO | Evotec SE | 1.12B | -7.12% | 37,181 | 925.65M |
| 348 | ZBIO | Zenas BioPharma, Inc. | 1.12B | -6.03% | 208,529 | 10.00M |
| 349 | IVA | Inventiva S.A. | 1.11B | -0.95% | 125,761 | 7.94M |
| 350 | QURE | uniQure N.V. | 1.10B | -1.46% | 378,221 | 16.10M |
| 351 | CRON | Cronos Group Inc. | 1.07B | -6.96% | 4,304,524 | 146.59M |
| 352 | ALVO | Alvotech | 1.06B | -3.14% | 160,108 | 588.90M |
| 353 | ORIC | ORIC Pharmaceuticals, Inc. | 1.05B | -2.41% | 574,002 | - |
| 354 | PNTG | The Pennant Group, Inc. | 1.05B | 2.62% | 65,132 | 947.71M |
| 355 | COLL | Collegium Pharmaceutical, Inc. | 1.05B | -1.83% | 132,273 | 780.57M |
| 356 | INNV | InnovAge Holding Corp. | 1.05B | 0.78% | 60,468 | 915.37M |
| 357 | BLFS | BioLife Solutions, Inc. | 1.04B | -5.70% | 169,749 | 96.21M |
| 358 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | -1.57% | 465,794 | 291.85M |
| 359 | NEO | NeoGenomics, Inc. | 1.02B | -4.10% | 957,847 | 727.33M |
| 360 | PCRX | Pacira BioSciences, Inc. | 1.01B | 0.64% | 273,600 | 726.41M |
| 361 | TDOC | Teladoc Health, Inc. | 1.01B | -5.15% | 2,337,030 | 2.53B |
| 362 | ANNX | Annexon, Inc. | 1.01B | -0.96% | 1,142,119 | - |
| 363 | CDNA | CareDx, Inc. | 981.31M | -7.13% | 229,959 | 379.81M |
| 364 | CTMX | CytomX Therapeutics, Inc. | 970.64M | -2.60% | 864,411 | 76.20M |
| 365 | GERN | Geron Corporation | 967.76M | -2.58% | 5,080,295 | 183.88M |
| 366 | KALV | KalVista Pharmaceuticals, Inc. | 961.45M | -4.04% | 1,137,281 | 73.62M |
| 367 | OMER | Omeros Corporation | 953.95M | -0.90% | 380,840 | - |
| 368 | CMPX | Compass Therapeutics, Inc. | 940.06M | -1.88% | 355,163 | 850.00K |
| 369 | SANA | Sana Biotechnology, Inc. | 938.36M | -7.32% | 1,361,368 | - |
| 370 | ANRO | Alto Neuroscience, Inc. | 930.30M | -2.28% | 116,020 | - |
| 371 | AMPH | Amphastar Pharmaceuticals, Inc. | 929.89M | -0.52% | 129,030 | 719.89M |
| 372 | OPK | OPKO Health, Inc. | 929.86M | -0.41% | 716,200 | 606.88M |
| 373 | EVMN | Evommune, Inc. | 924.23M | -5.38% | 98,887 | 13.00M |
| 374 | JANX | Janux Therapeutics, Inc. | 922.21M | -1.49% | 241,941 | 10.00M |
| 375 | PHAT | Phathom Pharmaceuticals, Inc. | 919.80M | -1.28% | 681,042 | 175.11M |
| 376 | CERT | Certara, Inc. | 916.12M | -6.35% | 1,761,776 | 418.84M |
| 377 | FTRE | Fortrea Holdings Inc. | 914.43M | -6.86% | 757,680 | 2.72B |
| 378 | XNCR | Xencor, Inc. | 910.87M | -3.35% | 117,446 | 125.58M |
| 379 | INMD | InMode Ltd. | 901.91M | -1.21% | 172,275 | 370.50M |
| 380 | SSII | SS Innovations International, Inc. | 900.73M | -2.07% | 24,809 | 42.48M |
| 381 | LMRI | Lumexa Imaging Holdings, Inc. | 896.71M | - | 205,708 | 1.02B |
| 382 | MGTX | MeiraGTx Holdings plc | 882.07M | -4.99% | 410,559 | 81.39M |
| 383 | LBRX | LB Pharmaceuticals Inc | 876.30M | -3.84% | 60,402 | - |
| 384 | DRUG | Bright Minds Biosciences Inc. | 875.40M | -1.41% | 103,236 | - |
| 385 | TALK | Talkspace, Inc. | 865.45M | -0.19% | 1,013,345 | 228.87M |
| 386 | CBIO | Crescent Biopharma, Inc. | 862.56M | -3.74% | 225,662 | 10.84M |
| 387 | MRVI | Maravai LifeSciences Holdings, Inc. | 854.75M | -9.89% | 1,143,407 | 185.74M |
| 388 | TBPH | Theravance Biopharma, Inc. | 846.03M | -0.84% | 105,323 | 107.46M |
| 389 | SLS | SELLAS Life Sciences Group, Inc. | 844.94M | -1.57% | 2,449,295 | - |
| 390 | OMDA | Omada Health, Inc. | 839.69M | -2.46% | 435,199 | 260.21M |
| 391 | SDGR | Schrödinger, Inc. | 837.18M | -8.18% | 1,152,669 | 255.87M |
| 392 | ABUS | Arbutus Biopharma Corporation | 832.07M | -4.63% | 812,533 | 14.08M |
| 393 | MNKD | MannKind Corporation | 827.57M | -2.19% | 1,450,312 | 348.97M |
| 394 | TLRY | Tilray Brands, Inc. | 825.79M | -9.72% | 35,078,640 | 858.28M |
| 395 | KURA | Kura Oncology, Inc. | 824.61M | -2.52% | 438,700 | 67.48M |
| 396 | IART | Integra LifeSciences Holdings Corporation | 818.34M | -2.33% | 168,533 | 1.64B |
| 397 | SLDB | Solid Biosciences Inc. | 809.79M | -2.02% | 282,258 | - |
| 398 | DSGN | Design Therapeutics, Inc. | 806.67M | -2.17% | 73,377 | - |
| 399 | BVS | Bioventus Inc. | 800.78M | -1.43% | 193,712 | 568.09M |
| 400 | SGP | SpyGlass Pharma, Inc. | 796.22M | -2.74% | 75,705 | - |
| 401 | SPRY | ARS Pharmaceuticals, Inc. | 795.37M | -4.64% | 1,112,873 | 84.28M |
| 402 | CBLL | CeriBell, Inc. | 793.29M | -1.20% | 79,774 | 89.06M |
| 403 | CGEM | Cullinan Therapeutics, Inc. | 791.68M | -5.49% | 203,072 | - |
| 404 | ALLO | Allogene Therapeutics, Inc. | 787.71M | -4.18% | 4,820,344 | 22.00K |
| 405 | VOR | Vor Biopharma Inc. | 777.02M | -6.40% | 406,070 | - |
| 406 | GDRX | GoodRx Holdings, Inc. | 774.22M | -4.64% | 727,619 | 796.85M |
| 407 | NUTX | Nutex Health Inc. | 773.49M | 2.41% | 88,076 | 875.26M |
| 408 | BIOA | BioAge Labs, Inc. | 769.54M | -5.56% | 198,028 | 9.00M |
| 409 | AMN | AMN Healthcare Services, Inc. | 768.10M | -4.97% | 136,830 | 2.73B |
| 410 | RLMD | Relmada Therapeutics, Inc. | 749.43M | 1.20% | 336,947 | - |
| 411 | QDEL | QuidelOrtho Corporation | 746.18M | -7.90% | 1,037,716 | 2.73B |
| 412 | LXRX | Lexicon Pharmaceuticals, Inc. | 722.38M | -6.32% | 1,178,254 | 49.80M |
| 413 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 717.09M | 1.01% | 234,426 | - |
| 414 | FBRX | Forte Biosciences, Inc. | 715.38M | -2.03% | 72,607 | - |
| 415 | CSTL | Castle Biosciences, Inc. | 713.47M | -6.18% | 95,140 | 344.23M |
| 416 | DRTS | Alpha Tau Medical Ltd. | 704.08M | -0.99% | 278,237 | - |
| 417 | EHAB | Enhabit, Inc. | 696.43M | - | 525,695 | 1.06B |
| 418 | TENX | Tenax Therapeutics, Inc. | 691.13M | -1.29% | 104,096 | - |
| 419 | GYRE | Gyre Therapeutics, Inc. | 680.46M | -3.60% | 26,052 | 116.59M |
| 420 | PRME | Prime Medicine, Inc. | 676.44M | -3.54% | 1,058,377 | 4.63M |
| 421 | ARVN | Arvinas, Inc. | 665.83M | -2.07% | 278,603 | 262.60M |
| 422 | TRAX | First Tracks Biotherapeutics, Inc. | 650.85M | -0.74% | 225,927 | - |
| 423 | BWAY | BrainsWay Ltd. | 648.57M | -0.32% | 45,601 | 52.23M |
| 424 | IRWD | Ironwood Pharmaceuticals, Inc. | 645.71M | -5.26% | 565,162 | 296.15M |
| 425 | ETON | Eton Pharmaceuticals, Inc. | 632.59M | -1.80% | 92,187 | 79.95M |
| 426 | ACRS | Aclaris Therapeutics, Inc. | 621.31M | 1.82% | 1,302,905 | 7.83M |
| 427 | HSTM | HealthStream, Inc. | 612.19M | -2.79% | 80,631 | 304.06M |
| 428 | PSNL | Personalis, Inc. | 606.09M | -8.24% | 1,000,082 | 69.65M |
| 429 | ANL | Adlai Nortye Ltd. | 605.60M | -6.14% | 237,331 | 5.00M |
| 430 | PROK | ProKidney Corp. | 600.90M | -4.78% | 323,342 | 893.00K |
| 431 | EIKN | Eikon Therapeutics, Inc. | 600.13M | -4.44% | 70,472 | - |
| 432 | STTK | Shattuck Labs, Inc. | 598.61M | 2.19% | 159,542 | 1.00M |
| 433 | ZVRA | Zevra Therapeutics, Inc. | 597.68M | -2.96% | 274,269 | 106.47M |
| 434 | SIBN | SI-BONE, Inc. | 591.15M | -3.50% | 116,624 | 200.93M |
| 435 | PRTA | Prothena Corporation plc | 579.24M | 0.37% | 256,101 | 9.68M |
| 436 | KYTX | Kyverna Therapeutics, Inc. | 578.67M | -6.55% | 1,317,347 | - |
| 437 | ABSI | Absci Corporation | 578.42M | 2.72% | 1,870,516 | 2.80M |
| 438 | CRMD | CorMedix Inc. | 577.23M | -1.74% | 319,265 | 311.71M |
| 439 | NPCE | NeuroPace, Inc. | 573.01M | 0.24% | 173,884 | 99.99M |
| 440 | ENGN | enGene Therapeutics Inc. | 569.41M | -0.47% | 299,353 | - |
| 441 | OCGN | Ocugen, Inc. | 568.71M | - | 3,279,647 | 4.41M |
| 442 | STRO | Sutro Biopharma, Inc. | 568.34M | -3.45% | 82,905 | 102.48M |
| 443 | RIGL | Rigel Pharmaceuticals, Inc. | 562.32M | -0.10% | 87,478 | 294.28M |
| 444 | TCMD | Tactile Systems Technology, Inc. | 553.52M | -2.52% | 115,759 | 329.52M |
| 445 | LYEL | Lyell Immunopharma, Inc. | 547.98M | -5.21% | 29,572 | 36.00K |
| 446 | CTKB | Cytek Biosciences, Inc. | 539.91M | -9.68% | 268,329 | 201.49M |
| 447 | PHR | Phreesia, Inc. | 538.36M | -4.94% | 458,282 | 480.59M |
| 448 | FULC | Fulcrum Therapeutics, Inc. | 538.13M | 4.26% | 379,456 | 80.00M |
| 449 | VSTM | Verastem, Inc. | 537.60M | 0.82% | 726,404 | 30.91M |
| 450 | EMBC | Embecta Corp. | 534.76M | -1.95% | 263,529 | 1.08B |
| 451 | IMMX | Immix Biopharma, Inc. | 532.77M | -1.28% | 184,795 | - |
| 452 | CGC | Canopy Growth Corporation | 526.86M | -12.32% | 51,353,528 | 203.04M |
| 453 | CATX | Perspective Therapeutics, Inc. | 526.76M | -1.91% | 1,517,313 | 884.00K |
| 454 | AVR | Anteris Technologies Global Corp. | 526.59M | -2.90% | 183,940 | 1.91M |
| 455 | ZURA | Zura Bio Limited | 525.64M | -2.64% | 182,404 | - |
| 456 | CADL | Candel Therapeutics, Inc. | 521.52M | -3.00% | 1,106,647 | - |
| 457 | TECX | Tectonic Therapeutic, Inc. | 519.74M | -2.88% | 68,636 | - |
| 458 | UPB | Upstream Bio, Inc. | 518.08M | -1.24% | 162,448 | 2.85M |
| 459 | ADCT | ADC Therapeutics SA | 507.49M | -2.44% | 278,753 | 81.36M |
| 460 | VREX | Varex Imaging Corporation | 506.81M | -0.41% | 52,306 | 854.40M |
| 461 | AGMB | AgomAb Therapeutics NV | 506.13M | -1.56% | 21,753 | - |
| 462 | ARMP | Armata Pharmaceuticals, Inc. | 505.53M | -0.79% | 15,764 | 4.90M |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 464 | BBNX | Beta Bionics, Inc. | 503.99M | -7.30% | 656,534 | 110.24M |
| 465 | AQST | Aquestive Therapeutics, Inc. | 499.77M | -1.33% | 652,991 | 44.55M |
| 466 | ESPR | Esperion Therapeutics, Inc. | 498.08M | -1.78% | 2,333,801 | 403.14M |
| 467 | MDXG | MiMedx Group, Inc. | 497.70M | 1.21% | 957,118 | 418.63M |
| 468 | FDMT | 4D Molecular Therapeutics, Inc. | 488.05M | -2.45% | 230,713 | 85.21M |
| 469 | OFIX | Orthofix Medical Inc. | 486.55M | -0.16% | 67,122 | 822.31M |
| 470 | VALN | Valneva SE | 485.03M | -1.33% | 220,842 | 205.07M |
| 471 | KMDA | Kamada Ltd. | 477.40M | -1.79% | 40,720 | 180.46M |
| 472 | PACB | Pacific Biosciences of California, Inc. | 474.14M | -8.19% | 3,166,691 | 160.01M |
| 473 | RGNX | REGENXBIO Inc. | 469.72M | -2.57% | 252,458 | 170.44M |
| 474 | AURA | Aura Biosciences, Inc. | 467.02M | -2.80% | 153,624 | - |
| 475 | CTNM | Contineum Therapeutics, Inc. | 466.70M | -3.55% | 44,145 | - |
| 476 | ANGO | AngioDynamics, Inc. | 463.92M | - | 116,090 | 313.73M |
| 477 | VTVT | vTv Therapeutics Inc. | 461.32M | -8.10% | 46,170 | 17.00K |
| 478 | FLGT | Fulgent Genetics, Inc. | 458.92M | -2.33% | 152,885 | 322.67M |
| 479 | TRDA | Entrada Therapeutics, Inc. | 458.28M | -2.45% | 39,058 | 25.42M |
| 480 | DNA | Ginkgo Bioworks Holdings, Inc. | 457.51M | -6.87% | 433,516 | 170.16M |
| 481 | LRMR | Larimar Therapeutics, Inc. | 455.01M | -3.95% | 545,647 | - |
| 482 | XOMA | XOMA Royalty Corporation | 452.32M | -3.58% | 26,720 | 52.15M |
| 483 | LXEO | Lexeo Therapeutics, Inc. | 450.45M | -3.95% | 526,802 | - |
| 484 | ASMB | Assembly Biosciences, Inc. | 443.76M | -1.15% | 36,583 | 72.30M |
| 485 | AVIR | Atea Pharmaceuticals, Inc. | 442.18M | -1.07% | 63,844 | - |
| 486 | BNTC | Benitec Biopharma Inc. | 436.06M | -1.77% | 66,822 | - |
| 487 | EPRX | Eupraxia Pharmaceuticals Inc. | 435.80M | 4.25% | 81,529 | - |
| 488 | MYGN | Myriad Genetics, Inc. | 434.91M | -9.35% | 526,367 | 824.50M |
| 489 | IVVD | Invivyd, Inc. | 427.03M | -5.63% | 907,733 | 53.43M |
| 490 | PRTC | PureTech Health plc | 424.18M | -1.96% | 1,448 | 6.39M |
| 491 | NGNE | Neurogene Inc. | 419.75M | -1.43% | 46,614 | 925.00K |
| 492 | CLYM | Climb Bio, Inc. | 418.93M | -5.70% | 250,205 | - |
| 493 | EBS | Emergent BioSolutions Inc. | 415.74M | -2.90% | 130,494 | 742.90M |
| 494 | XFOR | X4 Pharmaceuticals, Inc. | 415.50M | 3.39% | 358,295 | 35.11M |
| 495 | SRTA | Strata Critical Medical, Inc. | 413.22M | -4.40% | 363,704 | 197.14M |
| 496 | AUTL | Autolus Therapeutics plc | 412.52M | -3.13% | 672,124 | 75.39M |
| 497 | AGL | agilon health, inc. | 406.90M | -13.42% | 161,104 | 5.93B |
| 498 | KIDS | OrthoPediatrics Corp. | 406.48M | -1.77% | 33,219 | 236.35M |
| 499 | NMRA | Neumora Therapeutics, Inc. | 406.48M | -3.68% | 525,114 | - |
| 500 | RCKT | Rocket Pharmaceuticals, Inc. | 405.94M | -2.11% | 900,031 | - |